Protalix BioTherapeutics, Inc. Shares, Outstanding
Protalix BioTherapeutics, Inc. (PLX) had Shares, Outstanding of 148.38 million shares as of 2019-03-31, per its 10-Q filed 2019-05-06.
Discontinued › Shareholders' Equity
us-gaap:SharesOutstanding · last filed 2019-05-06
- 2019-03-31: Shares, Outstanding 148.38M shares.
- 2018-12-31: Shares, Outstanding 148.38M shares.
- 2018-03-31: Shares, Outstanding 145.57M shares.
- 2017-12-31: Shares, Outstanding 143.73M shares.
| Period end | Shares, Outstanding |
|---|---|
| 2019-03-31 | 148.38M shares 10-Q · filed 2019-05-06 |
| 2018-12-31 | 148.38M shares 10-Q · filed 2019-05-06 |
| 2018-03-31 | 145.57M shares 10-Q · filed 2019-05-06 |
| 2017-12-31 | 143.73M shares 10-Q · filed 2019-05-06 |
| 2013-03-31 | 93.50M shares 10-Q · filed 2013-05-09 |
| 2012-12-31 | 93.49M shares 10-Q · filed 2013-05-09 |
| 2012-03-31 | 90.82M shares 10-Q · filed 2013-05-09 |
| 2011-12-31 | 85.63M shares 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |